Entering text into the input field will update the search result below

PTIX Protagenic Therapeutics, Inc.
Stock Price & Overview

$0.830.01 (+1.51%)10:56 AM 12/11/23
NASDAQ | $USD | Delayed


Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Prev. Close

Quant Ranking

People Also Follow

Company Profile

Protagenic Therapeutics, Inc. logo
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company’s lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
  • 149 Fifth Avenue
  • Suite 500
  • New York, NY, 10010
  • United States
Phone Number
212 994 8200
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.